ARCHIVES

Three Studies Test Oncotype DX In Breast and Colon Cancers

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Generic Drug Makers Set Sights In Taxol Worldwide Market

April 2, 1993

Perjeta Neoadjuvant Therapy Granted Accelerated Approval In HER2 Breast Cancer

October 25, 2013

New Model For Risk Assessment Includes Alcohol, Exercise, Weight

July 29, 2011

NIH, Lasker Foundation Offer Clinical Research Opportunity

December 10, 2010

In Brief: appropriations Approved; Grants, contracts May Flow Unimpeded; NCI Positions An Issue

December 16, 1977

MSKCC Selects Hartford HealthCare As First Member in Cancer Alliance

September 27, 2013